Showing results (641-650 of 708) with videos related to
Sort By:
Pageof 71
American Journal of Hematology|October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromesAmer M Zeidan, Uma Borate, Daniel A Pollyea, et al.Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.Leukemia|March 30, 2019
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapyAreej El-Jawahri, Gregory A Abel, Lara Traeger, et al.American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.Ejhaem|July 18, 2022
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignanciesJoan How, Siyang Ren, Jennifer Lombardi-Story, et al.Leukemia Research|September 30, 2023
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromesTamanna Haque, Felix López Cadenas, Blanca Xicoy, et al.Proceedings of the National Academy of Sciences of the United States of America|June 10, 2011
FLOWERING LOCUS T duplication coordinates reproductive and vegetative growth in perennial poplarChuan-Yu Hsu, Joshua P Adams, Hyejin Kim, et al.Cancer|March 25, 2021
Posttraumatic stress disorder symptoms in patients with acute myeloid leukemiaHermioni L Amonoo, Thomas W LeBlanc, Alison R Kavanaugh, et al.Schmerz (Berlin, Germany)|April 15, 2017
[Interdisciplinary position paper "Perioperative pain management"]R Likar, W Jaksch, T Aigmüller, et al.Transplantation and Cellular Therapy|November 27, 2022
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice GuidelinesZachariah DeFilipp, Stefan O Ciurea, Corey Cutler, et al.Pageof 71